Characteristic | Number of patients | Number of Deaths |
---|---|---|
Age (years) | Â | Â |
   15–24 | 26 | 7 (26.9%) |
   25–34 | 129 | 39 (30.2%) |
   35–44 | 95 | 30 (31.6%) |
   ≥ 45 | 70 | 19 (27.1%) |
Sex | Â | Â |
   Male | 97 | 38 (39.2%) |
   Female | 223 | 57 (25.6%) |
Clinical stage | Â | Â |
   WHO stage I–II | 12 | 1 (8.3%) |
   WHO stage III | 98 | 18 (18.4%) |
   WHO stage IV | 210 | 76 (36.2%) |
BMI (kg/m 2 ) a | Â | Â |
   <16 | 98 | 46 (46.9%) |
   16–18.4 | 105 | 23 (21.9%) |
   ≥ 18.5 | 93 | 14 (15.1%) |
Hemoglobin (g/dL) b | Â | Â |
   <8 | 49 | 27 (55.1%) |
   8–9.9 | 108 | 43 (39.8%) |
   10–11.9 (10–12.9 for men) | 104 | 21 (20.2%) |
   ≥ 12 (≥ 13 for men) | 55 | 2 (3.6%) |
TLC (× 10 9 /L) c |  |  |
   <0.6 | 30 | 18 (60.0%) |
   0.6–1.1 | 116 | 32 (27.6%) |
   ≥ 1.2 | 166 | 42 (25.3%) |
Platelet count (× 10 9 /L) d |  |  |
   <150 | 52 | 24 (46.2%) |
   ≥ 150 | 261 | 66 (25.3%) |